Guidance for industry, q & a content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
| Other Authors: | Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.) |
|---|---|
| Format: | Electronic |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research,
[2000]
|
| Physical Description: |
1 online resource (4 unnumbered pages) |
| Subjects: | |
| Online Access: |
https://purl.fdlp.gov/GPO/LPS119805 |
https://purl.fdlp.gov/GPO/LPS119805
CMU Gov Pub Electronic
Electronic Resource Click Here| Location | Call Number: | Status |
|---|---|---|
| CMU Gov Pub Electronic | HE 20.4702:IN 8/2 | Available |